Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia

• Published in: Ethiopian journal of health sciences Vol. 28; no. 4; pp. 369 - 374
• Main Authors: Derbie, Awoke, Ayalew, Workneh, Mekonnen, Daniel, Alemu, Megbaru, Mulugeta, Yihun
• Format: Journal Article
• Language: English
• Published: Ethiopia Research and Publications Office of Jimma University 01.07.2018
• Subjects: Adolescent; Adult; AIDS-Related Opportunistic Infections - blood; AIDS-Related Opportunistic Infections - epidemiology; Ambulatory Care Facilities; Anti-HIV Agents - therapeutic use; Antigens, Fungal - blood; CD4 Lymphocyte Count; Child; Cryptococcosis - blood; Cryptococcosis - complications; Cryptococcosis - epidemiology; Cryptococcus; Ethiopia - epidemiology; Female; HIV Infections - blood; HIV Infections - complications; HIV Infections - immunology; Hospitals; Humans; Male; Middle Aged; Original; Retrospective Studies; Young Adult; Ethiopia; IMMY CrAg® LFA; Cryptococcal antigenemia; Bahir Dar; Ethiopia
• ISSN: 1029-1857; 2413-7170; 1029-1857
• DOI: 10.4314/ejhs.v28i4.2

Cryptococcosis is one of the common opportunistic fungal infections among HIV infected patients living in Sub-Saharan Africa, including Ethiopia. The magnitude of the disease at Felege Hiwot Referral Hospital (FHRH) in particular and in Ethiopia at large is not well explored. A retrospective document review and analysis was done on records of 137 HIV infected patients who visited FHRH ART clinic from 1 Sep to 30 Dec 2016 and had registered data on their sex, age, CD4 count and cryptococcal antigen screening result. The cryptoccocal antigen (CrAg) detection was done by the IMMY CrAg LFA (Cryptococcal Antigen Lateral Flow Assay) kit from patient serum as per the manufacturer's instruction. All data were entered, cleared, and analyzed using SPSS v20. Descriptive data analysis and cross tabulation were done to assess factors associated with cryptococcal antigenemia. Statistical significance was set at p-value less than or equal to 0.05. More than half of the participants, 54.7% (75/137), included in the study were females. The median age of the participants was 32.0 years (ranged: 8-52 years). The mean CD4 count was 51.8 with SD of 26.3 (range 3-98). All the patients were HIV stage IV. The proportion of positive cryptococal antigen from serum test was at 11.7% (95% CI: 7.3-18.1%). The IMMY CrAg LFA result was found statically associated with patient sex (p= 0.045). However, it was not associated with patient age group and the CD4 count (P>0.05). This study provided baseline data on the magnitude of cryptococcal antigenemia among HIV positive patients that is not touched before in the studied area. The results of the study showed that this opportunistic fungal infection is an important health concern among HIV patients. Further studies with sound design employing adequate sample size should be considered.